Samuel Dagogo-Jack, MD, FRCP, of the University of Tennessee Health Science Center (UTHSC) has received a $1.1 million grant to continue the Diabetes Prevention Program Outcomes Study (DPPOS). Dagogo-Jack who directs the Division of Endocrinology, Diabetes and Metabolism in the College of Medicine,
The grant from the National Institute of Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health, is for $228,000 a year over five years. Dagogo-Jack leads the UTHSC site of the study that includes research sites across the U.S. This phase of the study is an extension of the original Diabetes Prevention Program that was launched in 1996.
Dysglycemia – the abnormal regulation of blood sugar – covers a long sequence of events from pre-diabetes to the onset of Type 2 diabetes, the development of clinically detectable changes, and finally the clinical complications of diabetes, which can be life-threatening.
Dagogo-Jack led the original Diabetes Prevention Program at Washington University before joining UTHSC. Abbas Kitabchi, MD, led the UTHSC site and focused on the pre-diabetes stage and demonstrated the powerful beneficial effects of lifestyle intervention and the drug metformin in delaying or even preventing the onset of Type 2 diabetes.